Verona Pharma to trial lung drug ensifentrine for COVID-19

Verona Pharma to trial lung drug ensifentrine for COVID-19

Source: 
Pharmaforum
snippet: 

Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic.